Kazufumi Kikuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazufumi Kikuchi has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Koji Yamashita
Department of Molecular Imaging and Diagnosis, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
24 shared publications - Osamu Togao
Kyushu University
18 shared publications - Kousei Ishigami
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
15 shared publications - Akio Hiwatashi
Department of Radiology, Nagoya City University Graduate School of Medical Sciences , 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601
14 shared publications Osamu Togao
Department of Molecular Imaging and Diagnosis, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
10 shared publicationsKousei Ishigami
Department of Clinical Radiology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
8 shared publications
Latest Publications
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e254090
The Utility of Sodium Inversion Recovery MRI to Identify Astrocytoma, IDH -Mutant: A Prospective Pilot Study
Although further reduction of acquisition time is needed, 3-T sodium inversion recovery MRI may enhance current diagnostic approaches for detecting isocitrate dehydrogenase–mutant astrocytoma.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e254090
The Utility of Sodium Inversion Recovery MRI to Identify Astrocytoma, IDH -Mutant: A Prospective Pilot Study
Although further reduction of acquisition time is needed, 3-T sodium inversion recovery MRI may enhance current diagnostic approaches for detecting isocitrate dehydrogenase–mutant astrocytoma.
- 17 March 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (4) , e70271
Effect of the Temporal Sampling Strategy for the Assessment of Cerebral Perfusion in Multidelay Arterial Spin Labeling
Multidelay arterial spin labeling (ASL) MRI requires balancing temporal resolution with scan duration. The goal of the current study is to evaluate the influence of the temporal sampling strategy, implemented through temporal downsampling, on the quantitative accuracy of cerebral perfusion parameters obtained using multidelay ASL. In this prospective single‐center study, 12 healthy volunteers (mean age, 37 ± 9 years; seven men and five women) underwent multidelay pseudo‐continuous ASL on a 3‐T MRI system. Data were acquired using a variable time repetition scheme with 61 time points at a 75‐ms sampling interval. Cerebral blood flow (CBF) and arterial transit time (ATT) maps were calculated using seven temporally downsampled datasets with sampling intervals of 75 (gold standard), 150, 300, 450, 600, 750, and 900 ms. The normalized root mean square error (RMSE) between each sampling interval and the gold standard (75 ms) was calculated for both CBF and ATT. Additionally, subgroup analyses were performed for regions with ATT shorter or longer than the median, as determined from the 75‐ms interval dataset. The normalized RMSE of the CBF and ATT increased with more aggressive temporal downsampling. Across all sampling schemes, the normalized RMSE of CBF was significantly lower in regions with shorter ATT than in those with longer ATT ( p < 0.05). Temporal sampling configuration influences the quantitative reliability of CBF and ATT estimation. CBF bias is particularly pronounced in regions with prolonged ATT.
- 17 March 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (4) , e70271
Effect of the Temporal Sampling Strategy for the Assessment of Cerebral Perfusion in Multidelay Arterial Spin Labeling
Multidelay arterial spin labeling (ASL) MRI requires balancing temporal resolution with scan duration. The goal of the current study is to evaluate the influence of the temporal sampling strategy, implemented through temporal downsampling, on the quantitative accuracy of cerebral perfusion parameters obtained using multidelay ASL. In this prospective single‐center study, 12 healthy volunteers (mean age, 37 ± 9 years; seven men and five women) underwent multidelay pseudo‐continuous ASL on a 3‐T MRI system. Data were acquired using a variable time repetition scheme with 61 time points at a 75‐ms sampling interval. Cerebral blood flow (CBF) and arterial transit time (ATT) maps were calculated using seven temporally downsampled datasets with sampling intervals of 75 (gold standard), 150, 300, 450, 600, 750, and 900 ms. The normalized root mean square error (RMSE) between each sampling interval and the gold standard (75 ms) was calculated for both CBF and ATT. Additionally, subgroup analyses were performed for regions with ATT shorter or longer than the median, as determined from the 75‐ms interval dataset. The normalized RMSE of the CBF and ATT increased with more aggressive temporal downsampling. Across all sampling schemes, the normalized RMSE of CBF was significantly lower in regions with shorter ATT than in those with longer ATT ( p < 0.05). Temporal sampling configuration influences the quantitative reliability of CBF and ATT estimation. CBF bias is particularly pronounced in regions with prolonged ATT.
- 6 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (7) , 1869-1878
The Utility of Cystathionine Assessment Using Proton MRS for the Preoperative Differential Diagnosis of Adult-Type Diffuse Gliomas
Adult-type diffuse gliomas-astrocytoma, IDH-mutant; oligodendroglioma, IDH-mutant and 1p/19q-codeleted; and glioblastoma, IDH-wildtype-exhibit distinct prognoses and treatment responses. Accurate preoperative subtype estimation is therefore important for clinical decision-making. Proton MR spectroscopy (1H-MRS) enables noninvasive assessment of tumor metabolism. Cystathionine, detectable at 2.72 ppm, has been proposed as a metabolic marker of oligodendroglioma, but its diagnostic performance across adult-type diffuse gliomas remains incompletely defined. This study evaluated the utility of cystathionine quantification by 1H-MRS for differentiating glioma subtypes and assessed whether combined analysis with 2-hydroxyglutarate (2HG) improves diagnostic performance. Eighty-five patients with histologically and molecularly confirmed adult-type diffuse gliomas (25 oligodendrogliomas, 28 astrocytomas, 32 glioblastomas) underwent preoperative 3T MRI including single-voxel PRESS 1H-MRS (TE = 97 ms). Spectra with severe artifacts were excluded; no cases were excluded based on full width at half maximum (FWHM < 12.8 Hz, 0.1 ppm at 3T). Metabolites were quantified using LCModel, with concentrations normalized to the unsuppressed water signal and relaxation-corrected. Group comparisons of cystathionine levels were performed using Kruskal-Wallis and Bonferroni-corrected pairwise tests. The ROC analysis evaluated diagnostic performance for differentiating oligodendrogliomas from astrocytomas and glioblastomas. Supplementary analyses excluding spectra with cystathionine CRLB ≥ 50% and combined cystathionine-2HG ROC analyses were also performed. Cystathionine levels were highest in oligodendrogliomas (1.040 ± 0.908 mM), intermediate in glioblastomas, and lowest in astrocytomas (0.437 ± 0.403 mM). Oligodendrogliomas showed significantly higher levels than astrocytomas (P = 0.003), whereas no significant difference was observed between oligodendrogliomas and glioblastomas. ROC analysis showed moderate diagnostic performance (AUC = 0.69 for oligodendroglioma vs astrocytoma; AUC = 0.56 for oligodendroglioma vs glioblastoma). After CRLB-based exclusion, sensitivity increased but specificity decreased (AUC = 0.83 for oligodendroglioma vs astrocytoma). Combining cystathionine with 2HG modestly improved AUCs (0.72 and 0.61, respectively). Cystathionine quantification by 1H-MRS reflects biologically meaningful metabolic differences among adult-type diffuse gliomas, with higher levels characteristic of oligodendrogliomas compared with astrocytomas. However, overlap with glioblastomas limits its role as a stand-alone discriminator. When interpreted alongside 2HG and conventional imaging features, cystathionine may serve as a supportive metabolic marker to enhance preoperative glioma subtype classification.
- 6 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (7) , 1869-1878
The Utility of Cystathionine Assessment Using Proton MRS for the Preoperative Differential Diagnosis of Adult-Type Diffuse Gliomas
Adult-type diffuse gliomas-astrocytoma, IDH-mutant; oligodendroglioma, IDH-mutant and 1p/19q-codeleted; and glioblastoma, IDH-wildtype-exhibit distinct prognoses and treatment responses. Accurate preoperative subtype estimation is therefore important for clinical decision-making. Proton MR spectroscopy (1H-MRS) enables noninvasive assessment of tumor metabolism. Cystathionine, detectable at 2.72 ppm, has been proposed as a metabolic marker of oligodendroglioma, but its diagnostic performance across adult-type diffuse gliomas remains incompletely defined. This study evaluated the utility of cystathionine quantification by 1H-MRS for differentiating glioma subtypes and assessed whether combined analysis with 2-hydroxyglutarate (2HG) improves diagnostic performance. Eighty-five patients with histologically and molecularly confirmed adult-type diffuse gliomas (25 oligodendrogliomas, 28 astrocytomas, 32 glioblastomas) underwent preoperative 3T MRI including single-voxel PRESS 1H-MRS (TE = 97 ms). Spectra with severe artifacts were excluded; no cases were excluded based on full width at half maximum (FWHM < 12.8 Hz, 0.1 ppm at 3T). Metabolites were quantified using LCModel, with concentrations normalized to the unsuppressed water signal and relaxation-corrected. Group comparisons of cystathionine levels were performed using Kruskal-Wallis and Bonferroni-corrected pairwise tests. The ROC analysis evaluated diagnostic performance for differentiating oligodendrogliomas from astrocytomas and glioblastomas. Supplementary analyses excluding spectra with cystathionine CRLB ≥ 50% and combined cystathionine-2HG ROC analyses were also performed. Cystathionine levels were highest in oligodendrogliomas (1.040 ± 0.908 mM), intermediate in glioblastomas, and lowest in astrocytomas (0.437 ± 0.403 mM). Oligodendrogliomas showed significantly higher levels than astrocytomas (P = 0.003), whereas no significant difference was observed between oligodendrogliomas and glioblastomas. ROC analysis showed moderate diagnostic performance (AUC = 0.69 for oligodendroglioma vs astrocytoma; AUC = 0.56 for oligodendroglioma vs glioblastoma). After CRLB-based exclusion, sensitivity increased but specificity decreased (AUC = 0.83 for oligodendroglioma vs astrocytoma). Combining cystathionine with 2HG modestly improved AUCs (0.72 and 0.61, respectively). Cystathionine quantification by 1H-MRS reflects biologically meaningful metabolic differences among adult-type diffuse gliomas, with higher levels characteristic of oligodendrogliomas compared with astrocytomas. However, overlap with glioblastomas limits its role as a stand-alone discriminator. When interpreted alongside 2HG and conventional imaging features, cystathionine may serve as a supportive metabolic marker to enhance preoperative glioma subtype classification.
- 24 January 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (2) , 533-539
The diagnostic value of cortical high-flow sign combined with cystathionine on 1H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma
Objectives To leverage a combination of cortical high-flow sign on arterial spin labeling (ASL) and cystathionine measurement using 1H-MR spectroscopy (1H-MRS) to distinguish oligodendroglioma, IDH-mutant and 1p/19q-codeleted (O_IDHm-codel) from astrocytoma, IDH-mutant (A_IDHm-noncodel). Materials and methods We implemented pseudo-continuous ASL technique (post-labeling delay = 2000 ms) using a 3.0-T MRI scanner. Relative perfusion maps were generated by subtracting paired labeled images from control images. 1H-MRS data were acquired by using the single-voxel point-resolved spectroscopy sequence (PRESS) sequence (TR = 2000 ms, TE = 97 ms, NEX = 128, volume of interest = 203 mm3). Our study included cases with a Cramér-Rao Lower Bound of cystathionine levels at 2.7 ppm that were below 50%. The presence or absence of cortical high-flow sign and the estimated concentration of cystathionine were compared between A_IDHm-noncodel and O_IDHm-codel. The receiver operating characteristic curves were used to evaluate the diagnostic performance of each parameter, as well as the combination of both. Results The cortical high-flow sign was identified more frequent in O_IDHm-codel (7/12, 58.3%) than in A_IDHm-noncodel (3/18, 16.7%; p = 0.018). The cystathionine levels in O_IDHm-codel (1.50 ± 0.63 mM) was significantly higher than in A_IDHm-noncodel (0.85 ± 0.24 mM; p = 0.001). The area under the curve for distinguishing O_IDHm-codel from A_IDHm-noncodel using the presence of cortical high-flow sign, cystathionine levels, and their combination was 0.708 (0.509–0.908), 0.750 (0.553–0.947), and 0.875 (0.737–1.000), respectively. Conclusion The presence of cortical high-flow sign on ASL, along with elevated cystathionine levels measured by 1H-MRS, could differentiate O_IDHm-codel from A_IDHm-noncodel.
- 24 January 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (2) , 533-539
The diagnostic value of cortical high-flow sign combined with cystathionine on 1H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma
Objectives To leverage a combination of cortical high-flow sign on arterial spin labeling (ASL) and cystathionine measurement using 1H-MR spectroscopy (1H-MRS) to distinguish oligodendroglioma, IDH-mutant and 1p/19q-codeleted (O_IDHm-codel) from astrocytoma, IDH-mutant (A_IDHm-noncodel). Materials and methods We implemented pseudo-continuous ASL technique (post-labeling delay = 2000 ms) using a 3.0-T MRI scanner. Relative perfusion maps were generated by subtracting paired labeled images from control images. 1H-MRS data were acquired by using the single-voxel point-resolved spectroscopy sequence (PRESS) sequence (TR = 2000 ms, TE = 97 ms, NEX = 128, volume of interest = 203 mm3). Our study included cases with a Cramér-Rao Lower Bound of cystathionine levels at 2.7 ppm that were below 50%. The presence or absence of cortical high-flow sign and the estimated concentration of cystathionine were compared between A_IDHm-noncodel and O_IDHm-codel. The receiver operating characteristic curves were used to evaluate the diagnostic performance of each parameter, as well as the combination of both. Results The cortical high-flow sign was identified more frequent in O_IDHm-codel (7/12, 58.3%) than in A_IDHm-noncodel (3/18, 16.7%; p = 0.018). The cystathionine levels in O_IDHm-codel (1.50 ± 0.63 mM) was significantly higher than in A_IDHm-noncodel (0.85 ± 0.24 mM; p = 0.001). The area under the curve for distinguishing O_IDHm-codel from A_IDHm-noncodel using the presence of cortical high-flow sign, cystathionine levels, and their combination was 0.708 (0.509–0.908), 0.750 (0.553–0.947), and 0.875 (0.737–1.000), respectively. Conclusion The presence of cortical high-flow sign on ASL, along with elevated cystathionine levels measured by 1H-MRS, could differentiate O_IDHm-codel from A_IDHm-noncodel.
- 20 January 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-10
Time-intensity Profiles and T1-corrected Arterial Transit Time from Multi-delay Pseudo-continuous ASL with a Variable-TR Scheme for the Characterization of Adult-type Diffuse Glioma
Purpose The cerebral blood flow (CBF) measured by multi-delay ASL (4D-ASL) offers superior diagnostic performance compared to single-delay ASL-CBF for glioma grading. Dynamic changes in signal intensity (SI) and arterial transit time (ATT) obtained from 4D-ASL may also be key factors in differentiating adult-type diffuse glioma. Furthermore, the longitudinal relaxation time (T1) of brain tumor may influence on CBF and ATT when using ASL techniques. Our purpose was to determine if time-intensity profiles from 4D-ASL using a variable-TR scheme and T1-corrected ATT (ATTT1corr) could distinguish among adult-type diffuse gliomas. Materials and Methods The 4D-ASL with a variable-TR scheme data were collected by changing the labeling duration (LD) and post-labeling delay (PLD). Data acquisition at each phase consisted of pre-saturation and control or labeling modules followed by data acquisition. A total of 14 LD and PLD combinations were used. In addition, T1 measurement was conducted using pseudo-continuous ASL with a variable-TR scheme, without label and background suppression pulses. The SI peak time was obtained based on the time-intensity curve. The SI peak time, ATT, and ATTT1corr were compared among adult-type diffuse gliomas. Results Thirty patients were included in the study. ATT and the SI peak time in diffuse glioma with IDH-wildtype (IDHw) were significantly shorter than astrocytoma, IDH-mutant (p < 0.01, each). Moreover, ATTT1corr in astrocytoma, IDH-mutant was longer than the other types of diffuse glioma (p < 0.0001). Conclusion The 4D-ASL with a variable-TR scheme includes ATTT1corr and the SI peak time could potentially improve the differential diagnosis of adult-type diffuse gliomas.
- 20 January 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-10
Time-intensity Profiles and T1-corrected Arterial Transit Time from Multi-delay Pseudo-continuous ASL with a Variable-TR Scheme for the Characterization of Adult-type Diffuse Glioma
Purpose The cerebral blood flow (CBF) measured by multi-delay ASL (4D-ASL) offers superior diagnostic performance compared to single-delay ASL-CBF for glioma grading. Dynamic changes in signal intensity (SI) and arterial transit time (ATT) obtained from 4D-ASL may also be key factors in differentiating adult-type diffuse glioma. Furthermore, the longitudinal relaxation time (T1) of brain tumor may influence on CBF and ATT when using ASL techniques. Our purpose was to determine if time-intensity profiles from 4D-ASL using a variable-TR scheme and T1-corrected ATT (ATTT1corr) could distinguish among adult-type diffuse gliomas. Materials and Methods The 4D-ASL with a variable-TR scheme data were collected by changing the labeling duration (LD) and post-labeling delay (PLD). Data acquisition at each phase consisted of pre-saturation and control or labeling modules followed by data acquisition. A total of 14 LD and PLD combinations were used. In addition, T1 measurement was conducted using pseudo-continuous ASL with a variable-TR scheme, without label and background suppression pulses. The SI peak time was obtained based on the time-intensity curve. The SI peak time, ATT, and ATTT1corr were compared among adult-type diffuse gliomas. Results Thirty patients were included in the study. ATT and the SI peak time in diffuse glioma with IDH-wildtype (IDHw) were significantly shorter than astrocytoma, IDH-mutant (p < 0.01, each). Moreover, ATTT1corr in astrocytoma, IDH-mutant was longer than the other types of diffuse glioma (p < 0.0001). Conclusion The 4D-ASL with a variable-TR scheme includes ATTT1corr and the SI peak time could potentially improve the differential diagnosis of adult-type diffuse gliomas.
- 29 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (2) , 551-561
Relaxometry assessment of meningioma consistency using quantitative magnetic resonance imaging
Purpose To determine whether relaxometry assessment using synthetic MRI (SyMRI) can predict meningioma consistency. Methods Eighteen patients with histologically confirmed meningioma were included, and all patients underwent quantitative MRI on a 3T MRI system using a 2D multi-dynamic multi-cho sequence. Quantitative MRI software version 11.3 (SyntheticMR AB, Linköping, Sweden) was used to generate quantitative maps of T1, T2 relaxation times and proton density (PD). Regions of interest were manually placed over all tumor slices to evaluate three parameters (T1, T2, PD). Comparing with the conventional method, relative values of the tumor-to-thalamus signal intensity ratio on the non-contrast T1-weighted image (T1R) and T2-weighted image (T2R) and apparent diffusion coefficients generated from b-values (0 and 1000 s/mm2) of the diffusion-weighted image were also evaluated. The 10th, 25th, 50th, 75th, and 90th percentiles and mean values were calculated using histogram analysis. Meningioma consistency was intraoperatively assessed by neurosurgeons using a standardized 5-point scale, with tumors classified as soft (scores 1–2) or hard (scores 3–5). The Mann–Whitney U test and receiver operating characteristic analysis were performed. Results Soft meningiomas showed significantly longer T1 and T2 relaxation times and higher PDs than hard meningiomas (median value, p-value: 2701 vs. 1721 ms, p = 0.0009 for T1; 111 vs. 94 ms, p = 0.0047 for T2; 92 vs. 85%, p = 0.0092 for PD, respectively). The 90th percentile of T1 relaxation time exhibited the highest diagnostic performance for differentiating soft from hard meningiomas. Conclusion Relaxometry assessment offers a reliable method for predicting meningioma consistency that can optimize surgical planning.
- 29 December 2025
- Published by Springer Nature in Neuroradiology
- Vol. 68 (2) , 551-561
Relaxometry assessment of meningioma consistency using quantitative magnetic resonance imaging
Purpose To determine whether relaxometry assessment using synthetic MRI (SyMRI) can predict meningioma consistency. Methods Eighteen patients with histologically confirmed meningioma were included, and all patients underwent quantitative MRI on a 3T MRI system using a 2D multi-dynamic multi-cho sequence. Quantitative MRI software version 11.3 (SyntheticMR AB, Linköping, Sweden) was used to generate quantitative maps of T1, T2 relaxation times and proton density (PD). Regions of interest were manually placed over all tumor slices to evaluate three parameters (T1, T2, PD). Comparing with the conventional method, relative values of the tumor-to-thalamus signal intensity ratio on the non-contrast T1-weighted image (T1R) and T2-weighted image (T2R) and apparent diffusion coefficients generated from b-values (0 and 1000 s/mm2) of the diffusion-weighted image were also evaluated. The 10th, 25th, 50th, 75th, and 90th percentiles and mean values were calculated using histogram analysis. Meningioma consistency was intraoperatively assessed by neurosurgeons using a standardized 5-point scale, with tumors classified as soft (scores 1–2) or hard (scores 3–5). The Mann–Whitney U test and receiver operating characteristic analysis were performed. Results Soft meningiomas showed significantly longer T1 and T2 relaxation times and higher PDs than hard meningiomas (median value, p-value: 2701 vs. 1721 ms, p = 0.0009 for T1; 111 vs. 94 ms, p = 0.0047 for T2; 92 vs. 85%, p = 0.0092 for PD, respectively). The 90th percentile of T1 relaxation time exhibited the highest diagnostic performance for differentiating soft from hard meningiomas. Conclusion Relaxometry assessment offers a reliable method for predicting meningioma consistency that can optimize surgical planning.
- Open Access
- 24 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e93087
Cystathionine Detection via Proton Magnetic Resonance Spectroscopy (¹H-MRS) for the Diagnosis of Oligodendroglioma: A Case Report
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, is a subtype of adult-type diffuse gliomas that demonstrates a favorable prognosis and chemosensitivity. Typical imaging findings include a location in the frontal lobe and calcification on computed tomography (CT). However, differentiating it from other gliomas, such as glioblastoma, can be difficult when characteristic imaging features, like calcification, are absent. We present a case of a woman in her 30s with a ring-enhancing lesion in the right frontal lobe, initially suggestive of glioblastoma. Proton magnetic resonance spectroscopy (1H-MRS) was performed using a single-voxel, point-resolved spectroscopy sequence (PRESS) with an echo time of 97 ms. Spectral data were analyzed with LCModel (Stephen Provencher, Inc., Oakville, Canada), which revealed a distinct cystathionine peak at 2.7 ppm. This finding raised the suspicion of oligodendroglioma, which was confirmed by histopathological and molecular analyses. Cystathionine accumulation is attributed to the co-deletion of chromosome arm 1p, leading to downregulation of phosphoglycerate dehydrogenase and cystathionine gamma-lyase, and a metabolic shift toward the transsulfuration pathway. Although glioblastomas may also upregulate this pathway to resist ferroptosis, a previous study showed higher cystathionine levels in oligodendrogliomas. This case suggests that cystathionine detection by 1H-MRS could serve as a useful radiological clue in gliomas with atypical imaging features, which are a ring enhancement without calcification, assisting in the differential diagnosis.
- 24 September 2025
- Published by Springer Nature in Cureus
- Vol. 17 (9) , e93087
Open AccessCystathionine Detection via Proton Magnetic Resonance Spectroscopy (¹H-MRS) for the Diagnosis of Oligodendroglioma: A Case Report
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, is a subtype of adult-type diffuse gliomas that demonstrates a favorable prognosis and chemosensitivity. Typical imaging findings include a location in the frontal lobe and calcification on computed tomography (CT). However, differentiating it from other gliomas, such as glioblastoma, can be difficult when characteristic imaging features, like calcification, are absent. We present a case of a woman in her 30s with a ring-enhancing lesion in the right frontal lobe, initially suggestive of glioblastoma. Proton magnetic resonance spectroscopy (1H-MRS) was performed using a single-voxel, point-resolved spectroscopy sequence (PRESS) with an echo time of 97 ms. Spectral data were analyzed with LCModel (Stephen Provencher, Inc., Oakville, Canada), which revealed a distinct cystathionine peak at 2.7 ppm. This finding raised the suspicion of oligodendroglioma, which was confirmed by histopathological and molecular analyses. Cystathionine accumulation is attributed to the co-deletion of chromosome arm 1p, leading to downregulation of phosphoglycerate dehydrogenase and cystathionine gamma-lyase, and a metabolic shift toward the transsulfuration pathway. Although glioblastomas may also upregulate this pathway to resist ferroptosis, a previous study showed higher cystathionine levels in oligodendrogliomas. This case suggests that cystathionine detection by 1H-MRS could serve as a useful radiological clue in gliomas with atypical imaging features, which are a ring enhancement without calcification, assisting in the differential diagnosis.
- Open Access
- 21 January 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (2) , 361
Correction to: Artificial intelligence-assisted volume isotropic simultaneous interleaved bright- and black-blood examination for brain metastases
- 21 January 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (2) , 361
Open AccessCorrection to: Artificial intelligence-assisted volume isotropic simultaneous interleaved bright- and black-blood examination for brain metastases
- 20 January 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (2) , 291-298
The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density
Background and purpose The cortical high-flow sign has been more commonly reported in oligodendroglioma, IDH-mutant and 1p/19q-codeleted (ODG IDHm-codel) compared to diffuse glioma with IDH-wildtype or astrocytoma, IDH-mutant. Besides tumor types, higher grades of glioma might also contribute to the cortical high flow. Therefore, we investigated whether the histological cortical vascular density or CNS WHO grade was associated with the cortical high-flow sign in patients with ODG IDHm-codel. Materials and methods This retrospective study consisted of pathologically confirmed 25 adult patients with ODG IDHm-codel. We implemented pseudo-continuous arterial spin labeling technique with background suppression. Subtraction images were generated from paired control and label images. Tumor-affecting cortices without intense contrast enhancement on conventional MR imaging were targeted for the determination of the cortical high-flow sign. Immunohistochemical staining of CD31 antibody was performed for the identification of vascular endothelial cells. A microscopic field of the most intense vascularization was captured in each specimen. The vessel number and the relative vascular density (%Vessel) were compared between the positive cortical high-flow sign (CHFS+) and the negative cortical high-flow sign (CHFS−) groups using the Mann–Whitney U test. Second, Fisher’s exact test was used to compare the difference between the presence or absence of cortical high-flow sign and CNS WHO grades. Finally, the vessel number and %Vessel were compared between the CNS WHO grade 2 and grade 3 using the Mann–Whitney U test. Results The vessel number and %Vessel were higher in patients with the CHFS+ group than in patients with CHFS− group (p = 0.016 and p = 0.005, respectively). We observed no significant differences (p = 1.00) in the frequency of cortical high-flow sign between the CNS WHO grade 2 and grade 3. In addition, no significant differences are found in the vessel number and %Vessel between the CNS WHO grade 2 and grade 3 (p = 0.121 and p = 0.475, respectively). Conclusion The cortical high-flow sign on ASL, which is more commonly found in ODG IDHm-codel than in diffuse glioma with IDH-wildtype or astrocytoma, is associated with the histological cortical vascular density in patients with ODG IDHm-codel.
- 20 January 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (2) , 291-298
The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density
Background and purpose The cortical high-flow sign has been more commonly reported in oligodendroglioma, IDH-mutant and 1p/19q-codeleted (ODG IDHm-codel) compared to diffuse glioma with IDH-wildtype or astrocytoma, IDH-mutant. Besides tumor types, higher grades of glioma might also contribute to the cortical high flow. Therefore, we investigated whether the histological cortical vascular density or CNS WHO grade was associated with the cortical high-flow sign in patients with ODG IDHm-codel. Materials and methods This retrospective study consisted of pathologically confirmed 25 adult patients with ODG IDHm-codel. We implemented pseudo-continuous arterial spin labeling technique with background suppression. Subtraction images were generated from paired control and label images. Tumor-affecting cortices without intense contrast enhancement on conventional MR imaging were targeted for the determination of the cortical high-flow sign. Immunohistochemical staining of CD31 antibody was performed for the identification of vascular endothelial cells. A microscopic field of the most intense vascularization was captured in each specimen. The vessel number and the relative vascular density (%Vessel) were compared between the positive cortical high-flow sign (CHFS+) and the negative cortical high-flow sign (CHFS−) groups using the Mann–Whitney U test. Second, Fisher’s exact test was used to compare the difference between the presence or absence of cortical high-flow sign and CNS WHO grades. Finally, the vessel number and %Vessel were compared between the CNS WHO grade 2 and grade 3 using the Mann–Whitney U test. Results The vessel number and %Vessel were higher in patients with the CHFS+ group than in patients with CHFS− group (p = 0.016 and p = 0.005, respectively). We observed no significant differences (p = 1.00) in the frequency of cortical high-flow sign between the CNS WHO grade 2 and grade 3. In addition, no significant differences are found in the vessel number and %Vessel between the CNS WHO grade 2 and grade 3 (p = 0.121 and p = 0.475, respectively). Conclusion The cortical high-flow sign on ASL, which is more commonly found in ODG IDHm-codel than in diffuse glioma with IDH-wildtype or astrocytoma, is associated with the histological cortical vascular density in patients with ODG IDHm-codel.
- Open Access
- 1 January 2025
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 24 (4)
Improving Vessel Visibility and Applying Artificial Intelligence to Autodetect Brain Metastasis for a 3D MR Imaging Sequence Capable of Simultaneous Images with and without Blood Vessel Suppression
Purpose: The purposes of this study were 1) to improve vessel visibility of our MR sequence by modifying k-space filling and 2) to verify the usefulness of applying artificial intelligence (AI) for volume isotropic simultaneous interleaved bright- and black-blood examination (VISIBLE) with compressed sensitivity encoding (CS) in autodetecting brain metastases.Methods: We modified 3 sequences of VISIBLE (Centric, Reversed Centric, and Startup Echo 30). The Centric sequence is a prototype. The Reversed Centric filled the k-space in a reversed centric manner to improve vessel visibility. The Startup Echo 30 implemented dummy echoes to further improve vessel visibility. Vessel visibility was evaluated in one slice at the level of the centrum semiovale. The sensitivity, specificity, the area under the curve (AUC), and false positives of detecting brain metastases using AI were evaluated among 3 sequences. Statistical comparisons were performed using a one-way analysis of variance, followed by Friedman and Dunn’s multiple comparison tests.Results: The number of visualized vessels was significantly lower in the Centric (39.3 ± 9.7, P < 0.05) and Reversed Centric (44.2 ± 9.8, P < 0.05) methods than in the magnetization-prepared rapid gradient echo (49.3 ± 9.1) but comparable in the Startup Echo 30 method (44.9 ± 8.8, P > 0.05). No significant differences existed in sensitivity, specificity, and AUC among the 3 methods. False positives achieved using the Reversed Centric method were significantly fewer (54 false positives) than those achieved using the Centric (85 false positives) and Startup Echo 30 (68 false positives) methods (P = 0.0092).Conclusion: Vessel visibility was improved by modifying the k-space filling, which may reduce false positives. The AI model for VISIBLE with CS achieved good performance in autodetection of brain metastases. The AI model for VISIBLE with CS can help radiologists diagnose brain metastases in clinical practice.
- 1 January 2025
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 24 (4)
Open AccessImproving Vessel Visibility and Applying Artificial Intelligence to Autodetect Brain Metastasis for a 3D MR Imaging Sequence Capable of Simultaneous Images with and without Blood Vessel Suppression
Purpose: The purposes of this study were 1) to improve vessel visibility of our MR sequence by modifying k-space filling and 2) to verify the usefulness of applying artificial intelligence (AI) for volume isotropic simultaneous interleaved bright- and black-blood examination (VISIBLE) with compressed sensitivity encoding (CS) in autodetecting brain metastases.Methods: We modified 3 sequences of VISIBLE (Centric, Reversed Centric, and Startup Echo 30). The Centric sequence is a prototype. The Reversed Centric filled the k-space in a reversed centric manner to improve vessel visibility. The Startup Echo 30 implemented dummy echoes to further improve vessel visibility. Vessel visibility was evaluated in one slice at the level of the centrum semiovale. The sensitivity, specificity, the area under the curve (AUC), and false positives of detecting brain metastases using AI were evaluated among 3 sequences. Statistical comparisons were performed using a one-way analysis of variance, followed by Friedman and Dunn’s multiple comparison tests.Results: The number of visualized vessels was significantly lower in the Centric (39.3 ± 9.7, P < 0.05) and Reversed Centric (44.2 ± 9.8, P < 0.05) methods than in the magnetization-prepared rapid gradient echo (49.3 ± 9.1) but comparable in the Startup Echo 30 method (44.9 ± 8.8, P > 0.05). No significant differences existed in sensitivity, specificity, and AUC among the 3 methods. False positives achieved using the Reversed Centric method were significantly fewer (54 false positives) than those achieved using the Centric (85 false positives) and Startup Echo 30 (68 false positives) methods (P = 0.0092).Conclusion: Vessel visibility was improved by modifying the k-space filling, which may reduce false positives. The AI model for VISIBLE with CS achieved good performance in autodetection of brain metastases. The AI model for VISIBLE with CS can help radiologists diagnose brain metastases in clinical practice.